Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting

Overview of attention for article published in Therapeutics and Clinical Risk Management, May 2009

Altmetric Badge

Mentioned by

patent: 6 patents

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 1 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

Compositions and methods for treating centrally mediated nausea and vomiting

Grant US-11559523-B2

United States of America

Compositions and methods for treating centrally mediated nausea and vomiting

Grant US-10828297-B2

United States of America

Compositions and methods for treating centrally mediated nausea and vomiting

Application US-9943515-B2

United States of America

Compositions and methods for treating centrally mediated nausea and vomiting

Grant US-9186357-B2

United States of America

Compositions and methods for treating centrally mediated nausea and vomiting

Grant US-8951969-B2

United States of America

Compositions and methods for treating centrally mediated nausea and vomiting

Grant US-8623826-B2

United States of America